Risk factors as the basis for triage in low-resource cervical cancer screening programs

International Journal of Gynecology and Obstetrics

Volumn 80, Issue 1, 2003, Pages 41-47

  Gaffikin, L ^a   Ahmed, S ^a   Chen, Y Q ^a   McGrath, J M ^a   Blumenthal, P D ^a,b  

^a JHPIEGO   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cervical cancer screening; Risk factors; Triage; Visual inspection

Indexed keywords

ADULT; AGE; ARTICLE; CALCULATION; CANCER SCREENING; COMPUTER SIMULATION; CONTROLLED STUDY; DYSPLASIA; FEMALE; HEALTH PROGRAM; HUMAN; MEDICAL RECORD; OUTPATIENT DEPARTMENT; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CARCINOMA; ZIMBABWE;

EID: 0037225425     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(02)00373-9     Document Type: Article

References (33)

1. Kitchener H.C., Symonds P. Detection of cervical intraepithelial neoplasia in developing countries. Lancet. 353:1999;856-857.
2. Program for Applied Technology in Health (PATH): preventing cervical cancer in low-resource settings. Outlook. 18:2000;1-8.
3. Blumenthal P.D. Why visual inspection with acetic acid? Gaffikin L., Blumenthal P.D., Davis C., Brechin S.J.G. Alternatives for cervical cancer screening and treatment in low-resource settings. 1997;16-18 JHPIEGO Corporation, Baltimore.
4. Sankaranarayanan R., Shyamalakumary B., Wesley R., Sreedevi-Amma N., Parkin D.M., Nair M.K. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. Int J Cancer. 80:1999;161-163.
5. University of Zimbabwe/JHPIEGO Cervical Cancer Project: visual inspection with acetic acid for cervical cancer screening: test qualities in a primary care setting. Lancet. 353:1999;869-873.
6. Browner W.S., Newman T.B., Cummings S.R. Designing a new study: III. Diagnostic tests. Hulley S.B., Cummings S.R. Designing clinical research. 1988;87-97 Williams & Wilkins, Baltimore.
7. Blumenthal P., Gaffikin L., Chirenje Z.M., et al. with the University of Zimbabwe/JHPIEGO Cervical Cancer Project: Adjunctive testing for cervical cancer in low-resource settings with visual inspection, HPV, and the Pap smear. Int J Gynecol Obstet. 72:2001;47-53.
8. Ferris D.G., Wright T.C., Litaker M.S., Richart R.M., Lorincz A.T., Sun X.W., et al. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy? J Fam Pract. 46:1998;125-134.
9. Frisch L.E., Milner F.H., Ferris D.G. Naked-eye inspection of the cervix after acetic acid application may improve the predictive value of negative cytologic screening. J Fam Pract. 39:1996;457-460.
10. Riegelman R.K., Hirsch R.P. Studying a study and testing a test: how to read the medical literature. 1989;151-161 Little, Brown and Company, Boston.
11. Wright T.C., Lorincz A., Ferris D.G., Richart R.M., Ferenczy A., Mielzynska I., et al. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol. 178:1998;962-966.
12. Genton B., Smith T., Baea K., Nararam A., al-Yaman F., Beck H.P., et al. How useful are clinical criteria for improving the diagnosis in a highly endemic area? Trans R Soc Trop Med Hyg. 88:1994;537-541.
13. Hakama M., Pukkela P., Eeero P., Saastamoiner P. Selective screening theories: practice based on high risk groups of cervical cancer. J Epidemiol Community Health. 33:1979;257.
14. Hoyo C., Miller W.C., Newman B.M., Fortney J.A. Selective screening for cervical neoplasia: an approach for resource-poor settings. Int J Epidemiol. 29:2000;807-812.
15. Womack S.D., Chirenje Z.M., Gaffikin L., Blumenthal P.D., McGrath J.A., Chipato T., et al. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer. 85:2000;206-210.
16. Womack S.D., Chirenje Z.M., Blumenthal P.D., Gaffikin L., McGrath J.A., Chipato T., et al. Evaluation of a human papillomavirus (HPV) assay in cervical screening in Zimbabwe. Br J Obstet Gynecol. 107:2000;33-38.
17. Rosner B. Fundamentals of biostatistics. 5th ed:2000;Brooks and Cole.
18. Miller A.B. Cervical cancer screening programmes - managerial guidelines. 1992;6-48 World Health Organization, Geneva.
19. Kjaer S.K. Risk factors for cervical neoplasia in Denmark. APMIS Suppl. 80:1998;1-41.
20. Williams M.A., Kenya P.R., Mati J.K., Thomas D.B. Risk factors for invasive cervical cancer in Kenyan woman. Int J Epidemiol. 23:1994;906-912.
21. Learmonth G.M., Durcan C.M., Beck J.D. The changing incidence of cervical intra-epithelial neoplasia. S Afr Med J. 77:1990;637-639.
22. Sengupta S., Chaudhuri S.K., Das P., Raichaudhuri B., Pramanik R. Integrated approach to prediction of cervical intra-epithelial neoplasia status through a case-control study. Int J Cancer. 84:1999;69-73.
23. Heard I., Tassie J.M., Schmitz V., Mandelbrot L., Kazatchkine M.D., Orth G. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet Gynecol. 96:2000;403-409.
24. Maggwa B.N., Hunter D.J., Mbugua S., Tukei P., Mati J.K. The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya. AIDS. 7:1993;733-738.
25. Mandelblatt J.S., Fahs M., Garibaldi K., Senie R.T., Peterson H.B. Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions. AIDS. 6:1992;173-178.
26. Denny L., Kuhn L., Risi L., Richart R.M., Pollack A., Lorincz A., et al. Two-stage cervical cancer screening: an alternative for resource-poor settings. Am J Obstet Gynecol. 183:2000;383-388.
27. Sideri M., Spinaci L., Schettino F., Mezzetti M., Robertson C., Spolti N., et al. Risk factors for high-grade cervical intraepithelial neoplasia in patients with mild cytological dyskaryosis: human papillomavirus testing versus multivariate tree analysis of demographic data. Cancer Epidemiol Biomarkers Prev. 7:1998;237-242.
28. Castaneda-Iniguez M.S., Toledo-Cisneros R., Aguilera-Delgadillo M. Risk factors for cervico-uterine cancer in women in Zacatecas. Salud Publica Mex. 40:1998;330-338.
29. Chichareon S., Herrero R., Munoz N., Bosch F.X., Jacobs M.V., Deacon J., et al. Risk factors for cervical cancer in Thailand: a case control study. J Natl Cancer Inst. 90:1998;50-57.
30. Petzer A., Duncan M.E., Tibaux G., Mehari L. A study of cervical cancer in Ethiopian women. Cytopathology. 3:1992;139-148.
31. Bener A., Denic S., Alwash R. Screening for cervical cancer among Arab women. Int J Gynecol Obstet. 74:2001;305-307.
32. Lorenzato F., Singer A., Mould L., Santos L.C., Maia A., Cariri L. Cervical cancer detection by hybrid capture and evaluation of local risk factors. Int J Gynecol Obstet. 73:2001;41-46.
33. Sengupta S., Chaudhuri S.K., Das P., Raichaudhuri B., Pramanik R. Integrated approach to prediction of cervical intra-epithelial neoplasia status through a case-control study. Int J Cancer. 84:1999;69-73.